blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2588113

EP2588113 - A RECONSTITUTED HIGH DENSITY LIPOPROTEIN FORMULATION AND PRODUCTION METHOD THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.10.2017
Database last updated on 13.07.2024
FormerThe patent has been granted
Status updated on  11.11.2016
FormerGrant of patent is intended
Status updated on  07.11.2016
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
CSL Limited
45 Poplar Road
Parkville VIC 3052 / AU
[2013/19]
Inventor(s)01 / WRIGHT, Samuel
516 Hillside Avenue
Westfield New Jersey 07090 / US
02 / IMBODEN, Martin
Schlossmatte 4
CH-3110 Munsingen / CH
03 / BOLLI, Reinhard
Bellevuestrasse 14
CH-3073 Guemlingen / CH
04 / WAELCHLI, Marcel
Wohlhausenweg 2D
CH-3645 Gwatt / CH
 [2013/19]
Representative(s)Hauser, Hans-Peter, et al
CSL Behring GmbH Emil-von-Behring-Straße 76
D-35041 Marburg / DE
[2013/19]
Application number, filing date11799979.730.06.2011
[2016/50]
WO2011AU00819
Priority number, dateUS20100359925P30.06.2010         Original published format: US 359925 P
[2013/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012000048
Date:05.01.2012
Language:EN
[2012/01]
Type: A1 Application with search report 
No.:EP2588113
Date:08.05.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 05.01.2012 takes the place of the publication of the European patent application.
[2013/19]
Type: B1 Patent specification 
No.:EP2588113
Date:14.12.2016
Language:EN
[2016/50]
Search report(s)International search report - published on:AU05.01.2012
(Supplementary) European search report - dispatched on:EP05.11.2014
ClassificationIPC:A61K38/17, A61K31/685, A61K31/56, A61P9/10, A61P3/06
[2016/28]
CPC:
A61K38/1709 (EP,KR,US); A61K31/56 (EP,KR,US); A61K31/575 (EP,US);
A61K31/685 (EP,KR,US); A61K45/06 (EP,KR,US); A61K9/0019 (EP,KR,US);
A61K9/1275 (EP,KR,US); A61P3/06 (EP); A61P43/00 (EP);
A61P9/00 (EP); A61P9/10 (EP) (-)
C-Set:
A61K31/56, A61K2300/00 (US,EP);
A61K31/685, A61K2300/00 (EP,US);
A61K38/1709, A61K2300/00 (US,EP)
Former IPC [2013/19]A61K31/56, A61K31/685, A61P3/06, A61P9/10
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/19]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:REKONSTITUIERTE HOCHDICHTE LIPOPROTEINFORMULIERUNG UND HERSTELLUNGSVERFAHREN DAFÜR[2013/19]
English:A RECONSTITUTED HIGH DENSITY LIPOPROTEIN FORMULATION AND PRODUCTION METHOD THEREOF[2013/19]
French:FORMULATION DE LIPOPROTÉINES DE DENSITÉ ÉLEVÉE RECONSTITUÉES ET SON PROCÉDÉ DE PRODUCTION[2013/19]
Entry into regional phase30.01.2013National basic fee paid 
30.01.2013Search fee paid 
30.01.2013Designation fee(s) paid 
30.01.2013Examination fee paid 
Examination procedure30.01.2013Examination requested  [2013/19]
01.06.2015Amendment by applicant (claims and/or description)
20.06.2016Communication of intention to grant the patent
15.08.2016Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
22.09.2016Communication of intention to grant the patent
14.10.2016Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
14.10.2016Fee for grant paid
14.10.2016Fee for publishing/printing paid
07.11.2016Information about intention to grant a patent
07.11.2016Receipt of the translation of the claim(s)
Divisional application(s)EP16203579.4  / EP3178481
EP18215066.4  / EP3492085
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.06.2016
Opposition(s)15.09.2017No opposition filed within time limit [2017/47]
Fees paidRenewal fee
01.07.2013Renewal fee patent year 03
30.06.2014Renewal fee patent year 04
30.06.2015Renewal fee patent year 05
30.06.2016Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL14.12.2016
CY14.12.2016
EE14.12.2016
HR14.12.2016
LT14.12.2016
MC14.12.2016
MK14.12.2016
RO14.12.2016
RS14.12.2016
SI14.12.2016
SK14.12.2016
SM14.12.2016
BG14.03.2017
NO14.03.2017
GR15.03.2017
IS14.04.2017
PT14.04.2017
MT30.06.2017
[2020/33]
Former [2019/51]CY14.12.2016
EE14.12.2016
HR14.12.2016
LT14.12.2016
MC14.12.2016
MK14.12.2016
RO14.12.2016
RS14.12.2016
SI14.12.2016
SK14.12.2016
SM14.12.2016
BG14.03.2017
NO14.03.2017
GR15.03.2017
IS14.04.2017
PT14.04.2017
MT30.06.2017
Former [2019/46]CY14.12.2016
EE14.12.2016
HR14.12.2016
LT14.12.2016
MC14.12.2016
RO14.12.2016
RS14.12.2016
SI14.12.2016
SK14.12.2016
SM14.12.2016
BG14.03.2017
NO14.03.2017
GR15.03.2017
IS14.04.2017
PT14.04.2017
MT30.06.2017
Former [2018/43]EE14.12.2016
HR14.12.2016
LT14.12.2016
MC14.12.2016
RO14.12.2016
RS14.12.2016
SI14.12.2016
SK14.12.2016
SM14.12.2016
BG14.03.2017
NO14.03.2017
GR15.03.2017
IS14.04.2017
PT14.04.2017
MT30.06.2017
Former [2018/14]EE14.12.2016
HR14.12.2016
LT14.12.2016
MC14.12.2016
RO14.12.2016
RS14.12.2016
SI14.12.2016
SK14.12.2016
SM14.12.2016
BG14.03.2017
NO14.03.2017
GR15.03.2017
IS14.04.2017
PT14.04.2017
Former [2018/11]EE14.12.2016
HR14.12.2016
LT14.12.2016
MC14.12.2016
RO14.12.2016
RS14.12.2016
SK14.12.2016
SM14.12.2016
BG14.03.2017
NO14.03.2017
GR15.03.2017
IS14.04.2017
PT14.04.2017
Former [2017/43]EE14.12.2016
HR14.12.2016
LT14.12.2016
RO14.12.2016
RS14.12.2016
SK14.12.2016
SM14.12.2016
BG14.03.2017
NO14.03.2017
GR15.03.2017
IS14.04.2017
PT14.04.2017
Former [2017/28]HR14.12.2016
LT14.12.2016
RS14.12.2016
NO14.03.2017
GR15.03.2017
Documents cited:Search[XY]  - LERCH P G ET AL, "PRODUCTION AND CHARACTERIZATION OF A RECONSTITUTED HIGH DENSITY LIPOPROTEIN FOR THERAPEUTIC APPLICATIONS", VOX SANGUINIS, S. KARGER AG, BASEL, CH, (19960901), vol. 71, no. 3, doi:10.1046/J.1423-0410.1996.7130155.X, ISSN 0042-9007, pages 155 - 164, XP008009380 [X] 1,2,5-12,15-19,21,22 * page 157; table 1 * [Y] 3,4,13,14,20,23,24

DOI:   http://dx.doi.org/10.1046/j.1423-0410.1996.7130155.x
 [Y]  - TARDIF J C ET AL, "Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis - A randomized controlled trial", JAMA THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, AMERICAN MEDICAL ASSOCIATION, US, vol. 297, no. 15, doi:10.1001/JAMA.297.15.JPC70004, ISSN 0098-7484, (20070418), pages 1675 - 1682, (20070326), XP002720081 [Y] 1-24 * page 1676 * * page 1680 *

DOI:   http://dx.doi.org/10.1001/jama.297.15.jpc70004
 [Y]  - MATZ C E ET AL, "MICELLAR COMPLEXES OF HUMAN APO LIPO PROTEIN A-I WITH PHOSPHATIDYL CHOLINES AND CHOLESTEROL PREPARED FROM CHOLATE LIPID DISPERSIONS", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, (19820425), vol. 257, no. 8, ISSN 0021-9258, pages 4535 - 4540, XP002680274 [Y] 1-24 * page 4539; table II *
International search[A]US5652339  (LERCH PETER [CH], et al);
 [A]WO2010057203  (UNIV TEXAS [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.